Patents by Inventor Michael Puls

Michael Puls has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230043995
    Abstract: A process (51) for producing alternan-oligosaccharide (8), comprising contacting in a reactor (11) sucrose (9) with a catalytically effective amount of alternansucrase enzyme (13) and acceptor molecules (12), wherein the alternansucrase enzyme (13) and acceptor molecules (12) are present in the reactor (11) in an aqueous liquid (4) and the sucrose (9) is continuously or half-continuously fed to the reactor (11), and wherein the sucrose (9) and the acceptor molecules (12) are converted to alternan-oligosaccharide (8), and fructose (6) is formed as a by-product, continuously or half-continuously removing at least a part of the fructose (6) from the reactor (11) by membrane filtration (17).
    Type: Application
    Filed: January 8, 2021
    Publication date: February 9, 2023
    Inventors: Dominik Terfehr, Ralf Feldmann, Michael Puls
  • Patent number: 8536314
    Abstract: The present invention provides variants of fluorescent proteins, which are improved with regard to their properties for use as reporter proteins and/or in analytics. In particular, variants of fluorescent proteins are provided, which fluoresce brighter, show improved quantum yield and/or have shifted excitation or emission spectra. The fluorescent proteins according to the invention comprise in their LOV domain besides the substitution of a cysteine with an amino acid that does not covalently bind FMN at least one further point mutation.
    Type: Grant
    Filed: May 19, 2010
    Date of Patent: September 17, 2013
    Assignee: Evocatal GmbH
    Inventors: Thorsten Eggert, Sascha Hausmann, Michael Puls
  • Publication number: 20100304435
    Abstract: The present invention provides variants of fluorescent proteins, which are improved with regard to their properties for use as reporter proteins and/or in analytics. In particular, variants of fluorescent proteins are provided, which fluoresce brighter, show improved quantum yield and/or have shifted excitation or emission spectra. The fluorescent proteins according to the invention comprise in their LOV domain besides the substitution of a cysteine with an amino acid that does not covalently bind FMN at least one further point mutation.
    Type: Application
    Filed: May 19, 2010
    Publication date: December 2, 2010
    Applicant: EVOCATAL GMBH
    Inventors: Thorsten Eggert, Sascha Hausmann, Michael Puls